PUBLISHER: The Business Research Company | PRODUCT CODE: 1946991
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946991
Polymer biomaterials are non-reactive pharmacological materials derived from natural or synthetic sources. They are used to improve the performance of damaged tissues and organs involved in various therapeutic treatments.
The primary types of polymer biomaterials include silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, and others. Silicone rubber in polymer biomaterials refers to a rubber matrix lightly cross-linked with a polyacrylamide hydrogel and used for medical and biological applications. The material nature includes natural and synthetic forms. Polymer biomaterials are applied in cardiovascular care, ophthalmology, dentistry, plastic surgery, wound healing, tissue engineering, orthopedics, neurological and central nervous system disorders, and others.
Tariffs have increased the cost of imported medical grade polymers, additives, and processing equipment used in polymer biomaterials, creating pricing and supply challenges across the market. These impacts are most visible in high performance segments such as cardiovascular, ophthalmology, and tissue engineering applications, particularly in Europe and Asia where a large share of raw materials is sourced internationally. The resulting cost pressures have affected manufacturers' margins and slowed procurement cycles for hospitals and medical device companies. However, tariffs have also encouraged local production of polymer resins and compounding activities, supporting regional supply chains and improving long term cost stability for polymer biomaterial suppliers.
The polymer biomaterial market research report is one of a series of new reports from The Business Research Company that provides polymer biomaterial market statistics, including polymer biomaterial industry global market size, regional shares, competitors with a polymer biomaterial market share, detailed polymer biomaterial market segments, market trends and opportunities, and any further data you may need to thrive in the polymer biomaterial industry. This polymer biomaterial market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The polymer biomaterial market size has grown rapidly in recent years. It will grow from $94.98 billion in 2025 to $109.73 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to growth in orthopedic procedures, expansion of dental implants, rising cardiovascular surgeries, increased plastic surgery demand, adoption of synthetic materials.
The polymer biomaterial market size is expected to see rapid growth in the next few years. It will grow to $197.22 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to growth in regenerative medicine, increasing chronic diseases, expansion of implant technologies, rising demand for biodegradable materials, advancements in polymer chemistry. Major trends in the forecast period include rising demand for biocompatible polymers, growth of implantable medical devices, increasing use of synthetic biomaterials, expansion of tissue engineering applications, development of long-term durable polymers.
The increasing number of chronic diseases is increasingly supporting the expansion of the polymer biomaterial market going forward. Chronic diseases, also referred to as non-communicable diseases, are long-term conditions that persist over extended periods and often progress gradually. Polymer biomaterials are widely used in the development of implantable medical devices such as drug delivery pumps and neuromodulation electrodes. These applications help manage symptoms and enhance patient quality of life by providing long-term therapeutic support. For example, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system, 3,615,330 individuals registered with a general practitioner were identified as having non-diabetic hyperglycemia in 2023, reflecting an 18% increase compared to 2022. As a result, the rising prevalence of chronic diseases is reinforcing growth in the polymer biomaterial market.
Leading companies operating in the polymer biomaterial market are innovating new technologies, such as designed enzymatic biomaterials (DEB) technology, to improve performance and expand commercial opportunities. Designed enzymatic biomaterials technology represents a novel platform for producing high-performance polysaccharides through enzymatic processes. For example, in June 2023, International Flavors & Fragrances Inc., a US-based flavor and cosmetic ingredients company, launched its Enzymatic Biomaterials (DEB) technology. This sustainable biopolymer platform enables the production of biopolymers with performance characteristics comparable to petroleum-based polymers. The technology allows customization and fine-tuning of material properties by transferring functional attributes of petroleum-derived polymers into biopolymer components, supporting the development of sustainable, high-performance materials.
In July 2023, Biocoat, a US-based company focused on biocompatible coatings for medical devices, acquired Chempilots for an undisclosed amount. Through this acquisition, Biocoat sought to strengthen its polymer development capabilities and expand its range of biomedical product offerings. Chempilots is a Denmark-based company known for advanced polymer solutions that support the development of innovative medical technologies.
Major companies operating in the polymer biomaterial market are BASF SE, Corbion N.V., Zimmer Biomet Holdings Inc., Royal DSM N.V., Covestro AG, Evonik Industries AG, Starch Medical Inc., Victrex plc, W. L. Gore and Associates Inc., DSM Biomedical B.V., Purac Biomaterials, Ticona LLC, Invibo LLC, Covalon Technologies Ltd., Osteotech Inc., Medtronic plc, Stryker Corporation, Synthes Inc., Polyfibre Industries Pte Ltd., Toray Industries Inc., Stein Fibers Ltd., Bezwada Biomedical LLC, Collagen Solutions plc, Gelita AG, AorTech Biomaterials Pty Ltd., Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioHorizons IPH Inc., Biomerics LLC, Bioteque Corporation, CollPlant Holdings Ltd., EndoShape Inc., PolyNovo Biomaterials Pty Ltd., Secant Group LLC
North America was the largest region in the polymer biomaterials market in 2025. Western Europe was the second-largest region in the global polymer biomaterials market report. The regions covered in the polymer biomaterial market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the polymer biomaterial market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The polymer biomaterials market consists of sales of PCL, PVDF, PLGA, PVP, and nylon. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Polymer Biomaterial Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses polymer biomaterial market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for polymer biomaterial ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polymer biomaterial market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.